Work

Myeloablative fludarabine and busulfan regimen in myelofibrosis: Long term outcomes and analysis of prognostic factors.

Year: 2020

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2020.38.15_suppl.e19520

Authors: Jacinth Joseph, Denai R. Milton, Julianne Chen, Gheath Alatrash, Amin Majid Alousi, Qaiser Bashir, Stefan O. Ciurea, May Daher, Jin Seon Im, Rohtesh S. Mehta, Betul Oran, Amanda Leigh Olson, Neeraj Saini, Samer Ali Srour, Borje Andersson, Richard E. Champlin, Uday R. Popat

Institution: The University of Texas MD Anderson Cancer Center

Language: English

Topic: Myeloproliferative Neoplasms: Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W3032778198

Cites:

Cited by:

Related to: 10